EUVIMEDEUVIMED entdecken
BeobachtungsstudieLeitlinie

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Christian Basile iD, Felix Lindberg iD, Lina Benson iD, Federica Guidetti iD, Ulf Dahlström iD, Massimo Francesco Piepoli, Peter Mol, Raffaele Scorza iD, Aldo Pietro Maggioni iD, Lars H Lund iD, Gianluigi Savarese iD

Circulation · 01.04.2025 · 151 (13) · 931-945

DOI: 10.1161/circulationaha.124.072855 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Circulation, erschienen am 01.04.2025. Verfasst von Christian Basile und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden (C.B., F.L., L.B., F.G., R.S., G.S.), Karolins…. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Withholding Treatment. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) and an ejection fraction (EF) that has improved over time. This study assessed rates of, patient profiles, and associations with morbidity/mortality of renin-angiotensin inhibitors (RASi), angiotensin receptor–neprilysin inhibitors (ARNi), beta-blockers (BBL), and mineralocorticoid receptor antagonists (MRA) withdrawal in patients with HF with improved EF. METHODS: Patients with a first recorded EF

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureStroke VolumeWithholding TreatmentHumansFemaleMaleAgedRetrospective StudiesMiddle AgedRegistriesMineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsAngiotensin Receptor AntagonistsSwedenAngiotensin-Converting Enzyme InhibitorsPractice Guidelines as TopicTreatment Outcome

Stichwörter der Autor:innen

beta-blockersheart failuremineralocorticoid receptor antagonistsregistriesrenin-angiotensin systemwithholding treatment

Substanzen

Mineralocorticoid Receptor AntagonistsAdrenergic beta-AntagonistsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden (C.B., F.L., L.B., F.G., R.S., G.S.), Karolinska Institutet, Stockholm, Sweden.
  • Department of Advanced Biomedical Sciences, University of Naples "Federico II," Italy (C.B.).
  • National Association of Hospital Cardiologists (ANMCO) Research Center, Heart Care Foundation, Florence, Italy (C.B., A.P.M.).
  • Department of Health, Medicine, and Caring Sciences, Linkoping University, Sweden (U.D.).
  • Clinical Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy (M.P.).
  • Department of Biomedical Science for Health, University of Milan, Italy (M.P.).

ORCID-Profile: Christian Basile, Felix Lindberg, Lina Benson, Federica Guidetti, Ulf Dahlström, Raffaele Scorza, Aldo Pietro Maggioni, Lars H Lund, Gianluigi Savarese

Zitieren

APA

Basile, C., Lindberg, F., Benson, L., Guidetti, F., Dahlström, U., Piepoli, M. F., Mol, P., Scorza, R., Maggioni, A. P., Lund, L. H., & Savarese, G. (2025). Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction. Circulation, 151(13), 931-945. https://doi.org/10.1161/circulationaha.124.072855

Vancouver

Basile C, Lindberg F, Benson L, Guidetti F, Dahlström U, Piepoli MF, et al. Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction. Circulation. 2025;151(13):931-945. doi:10.1161/circulationaha.124.072855

BibTeX
@article{Basile2025,
  author = {Basile, Christian and Lindberg, Felix and Benson, Lina and Guidetti, Federica and Dahlström, Ulf and Piepoli, Massimo Francesco and Mol, Peter and Scorza, Raffaele and Maggioni, Aldo Pietro and Lund, Lars H and Savarese, Gianluigi},
  title = {Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {13},
  pages = {931--945},
  doi = {10.1161/circulationaha.124.072855}
}
Kostenlos starten →